The natural history of corticosteroid therapy for inflammatory bowel disease: a population-based study.

By W. Faubion, E. Loftus, W. Harmsen, A. Zinsmeister, W. Sandborn. Gastroenterology, 2001

1,177 citations recorded by the source corpus.

Subfields: Epidemiology, Genetics

View Paper: https://www.semanticscholar.org/paper/667792669b472173fcf927fbe87efe1469d6b102

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Epidemiology

1. W. Sandborn
2. J. Colombel
3. S. Hanauer
4. Markus F. Neurath

In Genetics

1. W. Sandborn
2. J. Colombel
3. S. Hanauer
4. G. Lichtenstein
5. B. Feagan
6. P. Rutgeerts
7. Bruce E. Sands
8. Markus F. Neurath

Citations in the corpus

• Combination therapy with infliximab and azathioprine is superior to monotherapy with either agent in ulcerative colitis. (2014, neutral): “Patients with appropriate samples 22 (28) 37 (47) 31 (39) Positive for IFX antibodies 0 7 (19) 1 (3) Negative for IFX antibodies 13 (59) 7 (19) 6 (19) Inconclusive 9 (41) 23 (62) 24 (77) Missing samples 24 (30) 16 (21) 16 (20) Unevaluable samples 33 (42) 25 (32) 33 (41)”
• Management of Crohn's Disease in Adults (2001, background): “Once patients are started on corticosteroids, up to 38p of patients will require surgery within 1 year thereafter (”